Denise Pollard-Knight, Director at OncoMed Pharmaceuticals Inc (OMED), sold 11,485 shares at $23.59 ($271K) on 2014-06-30, disclosed to the SEC on 2014-07-02.
Open-market sale of $271k OMED by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OMED | SELL | 2014-12-23 | $448K | — | Filing → |
| OMED | SELL | 2014-12-10 | $717K | — | Filing → |
| OMED | SELL | 2014-12-05 | $540K | — | Filing → |